2713-62-4

Usage

Uses

Used in Pharmaceutical Industry:
2-(HEXAFLUORO-2-HYDROXYISOPROPYL)ANILINE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 2-(HEXAFLUORO-2-HYDROXYISOPROPYL)ANILINE is utilized as an intermediate in the production of agrochemicals, potentially enhancing the effectiveness of pesticides and other agricultural products.
Used in Specialty Applications:
2-(HEXAFLUORO-2-HYDROXYISOPROPYL)ANILINE is employed in various industries for specialty applications, capitalizing on its unique properties to create specialized products or improve existing ones.
It is important to handle 2-(HEXAFLUORO-2-HYDROXYISOPROPYL)ANILINE with care, as it can be toxic when inhaled or ingested, and it may also cause skin and eye irritation.

Upstream product

• 3422-01-3 tert-butyl phenylcarbamate 
• 594-19-4 tert.-butyl lithium 
• 62-53-3 aniline 
• 684-16-2 Hexafluoroacetone 

Downstream Products

• 1034331-44-6 (E)-3-naphthalen-2-yl-N-[2-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]-acrylamide 
• 851519-99-8 2-imino-N-[2-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]-acetamide 
• 2396-15-8 o-(Heptafluor-isopropyl)-anilin 

Relevant academic research and scientific papers

Synthesis and inhibitory activity on hepatitis C virus RNA replication of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analogs

Using our recently developed assay system for full-genome-length hepatitis C virus (HCV) RNA replication in human hepatoma-derived Li23 cells (ORL8), we identified 4-(1,1,1,3,3,3-hexafluoro-2-hydroxy-2-propyl)aniline analog 1a as a novel HCV inhibitor. St

Methods of treating hormone-related conditions using cyclothiocarbamate derivatives

The present invention provides methods of inducing contraception which includes delivering to a female a composition containing a compound of formula I or formula II, or tautomers thereof, in a regimen which involves delivering one or more of a selective

Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders

The present invention provides methods of treating skin disorders includes delivering to a mammal a composition containing a compound of formula I, or tautomers thereof, in a regimen, wherein formula I is: and wherein R1-R5 and Qsup

USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN TREATMENT OF HORMONE-RELATED CONDITIONS

The present invention provides methods of inducing contraception which includes delivering to a female a composition containing a compound of formula I, formula II, or tautomers thereof, in a regimen which involves delivering one or more of a selective es